Simulating rabies post-exposure prophylaxis among patients with human immunodeficiency virus infection using a six-dose Essen regimen administrated with human diploid cell vaccine: A single-arm pilot study in Chinese population
Human Vaccines & Immunotherapeutics · 2025
DOI: 10.1080/21645515.2025.2500263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Vaccines & Immunotherapeutics, 2025. Verfasst von Huanyu Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Disease and Liver Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, Ch…. Hauptthemen laut MEDLINE: Post-Exposure Prophylaxis, HIV Infections, Rabies, Rabies Vaccines. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The guiding project of Jiangsu Commission of Health.
Abstract (Originalsprache)
To explore the immunogencity and safety of HDCV using a six-dose Essen regimen in human immunodeficiency virus (HIV) infected patients. We conducted a single-arm pilot study by simulating post-exposure prophylaxis (PEP) in HIV-infected patients. All patients were administrated with HDCV using a 6-dose Essen regimen (consisting of 2 doses on day 0, and 4 doses each on day 3, 7, 14, and 28). Rabies virus-neutralizing antibody (RVNA) titers were detected on day 0, 7, 14, and 45, separately. The adverse reactions were also observed. In addition, we divided the patients with the baseline CD4+ T-cell counts of 500 cells/μL to examine the correlation between primary CD4+ T-cell counts and RVNA titers among HIV patients. Thirty patients included in the study were mostly male (96.7%), with a median age of 30.5 years and stable antiretroviral therapy (ART) treatment. Patients had RVNA titers of 0.84 IU/mL on day 7, 9.94 IU/mL on day 14, and 4.02 IU/mL on day 45 after vaccination, with significant differences between day 7 and day 14. The seroconversion rate reached 100% on day 14. Only three patients developed transient adverse reactions(including fever and redness, swelling, pain, and induration at the injection site). There was no significant difference in antibody titers and safety profile between patients with CD4+T-cell counts below and above 500 cells/μL. A favorable immune response was achieved in HIV patients using the six-dose Essen regimen with HDCV. The safety profile of HDCV is satisfactory, with no major adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Disease and Liver Disease, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
- Chengdu Kanghua Biological Products Co., Ltd., Chengdu, China.
- Department of Infection Management, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Emergency Medicine, The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
Förderung
- The guiding project of Jiangsu Commission of Health
Zitieren
APA
Wu, H., Ye, W., Deng, X., Guo, L., Chen, C., & Jiang, H. (2025). Simulating rabies post-exposure prophylaxis among patients with human immunodeficiency virus infection using a six-dose Essen regimen administrated with human diploid cell vaccine: A single-arm pilot study in Chinese population. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2025.2500263
Vancouver
Wu H, Ye W, Deng X, Guo L, Chen C, Jiang H. Simulating rabies post-exposure prophylaxis among patients with human immunodeficiency virus infection using a six-dose Essen regimen administrated with human diploid cell vaccine: A single-arm pilot study in Chinese population. Human Vaccines & Immunotherapeutics. 2025. doi:10.1080/21645515.2025.2500263
BibTeX
@article{Wu2025,
author = {Wu, Huanyu and Ye, Wei and Deng, Xiaoming and Guo, Lili and Chen, Chao and Jiang, Hao},
title = {Simulating rabies post-exposure prophylaxis among patients with human immunodeficiency virus infection using a six-dose Essen regimen administrated with human diploid cell vaccine: A single-arm pilot study in Chinese population},
journal = {Human Vaccines & Immunotherapeutics},
year = {2025},
doi = {10.1080/21645515.2025.2500263}
}
EUVIMED